nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP2D6—Parkinson's disease	0.814	1	CbGaD
Ipratropium bromide—Dexmethylphenidate—SLC6A3—Parkinson's disease	0.00253	0.26	CrCbGaD
Ipratropium bromide—Methylphenidate—SLC6A3—Parkinson's disease	0.00253	0.26	CrCbGaD
Ipratropium bromide—Dexmethylphenidate—CYP2D6—Parkinson's disease	0.00133	0.136	CrCbGaD
Ipratropium bromide—Methylphenidate—CYP2D6—Parkinson's disease	0.00133	0.136	CrCbGaD
Ipratropium bromide—Trospium—CYP2D6—Parkinson's disease	0.00117	0.12	CrCbGaD
Ipratropium bromide—Scopolamine—ABCB1—Parkinson's disease	0.000852	0.0874	CrCbGaD
Ipratropium bromide—CHRM2—forebrain—Parkinson's disease	0.000361	0.0503	CbGeAlD
Ipratropium bromide—CHRM1—forebrain—Parkinson's disease	0.000329	0.0458	CbGeAlD
Ipratropium bromide—CHRM2—cardiovascular system—Parkinson's disease	0.000305	0.0426	CbGeAlD
Ipratropium bromide—CHRM5—head—Parkinson's disease	0.000301	0.042	CbGeAlD
Ipratropium bromide—CHRM3—forebrain—Parkinson's disease	0.000294	0.041	CbGeAlD
Ipratropium bromide—CYP2D6—hindbrain—Parkinson's disease	0.000288	0.0401	CbGeAlD
Ipratropium bromide—CHRM5—nervous system—Parkinson's disease	0.000286	0.0398	CbGeAlD
Ipratropium bromide—CHRM1—cardiovascular system—Parkinson's disease	0.000278	0.0387	CbGeAlD
Ipratropium bromide—CHRM5—central nervous system—Parkinson's disease	0.000275	0.0383	CbGeAlD
Ipratropium bromide—SLC22A4—spinal cord—Parkinson's disease	0.00024	0.0335	CbGeAlD
Ipratropium bromide—CHRM5—brain—Parkinson's disease	0.000218	0.0304	CbGeAlD
Ipratropium bromide—CHRM2—head—Parkinson's disease	0.000207	0.0288	CbGeAlD
Ipratropium bromide—CHRM2—nervous system—Parkinson's disease	0.000196	0.0273	CbGeAlD
Ipratropium bromide—SLC22A4—cerebellum—Parkinson's disease	0.00019	0.0265	CbGeAlD
Ipratropium bromide—CHRM2—central nervous system—Parkinson's disease	0.000189	0.0263	CbGeAlD
Ipratropium bromide—CHRM1—head—Parkinson's disease	0.000188	0.0262	CbGeAlD
Ipratropium bromide—CHRM1—nervous system—Parkinson's disease	0.000178	0.0249	CbGeAlD
Ipratropium bromide—SLC22A5—medulla oblongata—Parkinson's disease	0.000178	0.0248	CbGeAlD
Ipratropium bromide—CHRM1—central nervous system—Parkinson's disease	0.000172	0.024	CbGeAlD
Ipratropium bromide—CHRM3—head—Parkinson's disease	0.000168	0.0235	CbGeAlD
Ipratropium bromide—CYP2D6—brainstem—Parkinson's disease	0.000165	0.023	CbGeAlD
Ipratropium bromide—SLC22A5—midbrain—Parkinson's disease	0.000163	0.0227	CbGeAlD
Ipratropium bromide—CHRM3—nervous system—Parkinson's disease	0.00016	0.0223	CbGeAlD
Ipratropium bromide—CYP2D6—forebrain—Parkinson's disease	0.000159	0.0222	CbGeAlD
Ipratropium bromide—SLC22A5—spinal cord—Parkinson's disease	0.000159	0.0221	CbGeAlD
Ipratropium bromide—SLC22A4—brain—Parkinson's disease	0.000155	0.0215	CbGeAlD
Ipratropium bromide—CHRM3—central nervous system—Parkinson's disease	0.000154	0.0214	CbGeAlD
Ipratropium bromide—CHRM2—brain—Parkinson's disease	0.00015	0.0209	CbGeAlD
Ipratropium bromide—CHRM1—brain—Parkinson's disease	0.000136	0.019	CbGeAlD
Ipratropium bromide—SLC22A5—cerebellum—Parkinson's disease	0.000126	0.0176	CbGeAlD
Ipratropium bromide—CHRM3—brain—Parkinson's disease	0.000122	0.017	CbGeAlD
Ipratropium bromide—SLC22A5—brain—Parkinson's disease	0.000102	0.0143	CbGeAlD
Ipratropium bromide—CYP2D6—head—Parkinson's disease	9.11e-05	0.0127	CbGeAlD
Ipratropium bromide—CYP3A4—nervous system—Parkinson's disease	8.78e-05	0.0122	CbGeAlD
Ipratropium bromide—CYP2D6—nervous system—Parkinson's disease	8.64e-05	0.012	CbGeAlD
Ipratropium bromide—CYP3A4—central nervous system—Parkinson's disease	8.45e-05	0.0118	CbGeAlD
Ipratropium bromide—CYP2D6—central nervous system—Parkinson's disease	8.32e-05	0.0116	CbGeAlD
Ipratropium bromide—CYP2D6—cerebellum—Parkinson's disease	8.13e-05	0.0113	CbGeAlD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.46e-05	0.000441	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	7.35e-05	0.000435	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	7.33e-05	0.000433	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	7.31e-05	0.000432	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.29e-05	0.000431	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—OMD—Parkinson's disease	7.29e-05	0.000431	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	7.28e-05	0.000431	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	7.26e-05	0.000429	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—DDC—Parkinson's disease	7.22e-05	0.000427	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	7.21e-05	0.000427	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	7.2e-05	0.000426	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	7.17e-05	0.000424	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.15e-05	0.000423	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	7.1e-05	0.00042	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	7.06e-05	0.000418	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.05e-05	0.000417	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	7.04e-05	0.000416	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	7.03e-05	0.000416	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	6.97e-05	0.000412	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.91e-05	0.000409	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	6.84e-05	0.000404	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	6.81e-05	0.000403	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTA4—Parkinson's disease	6.81e-05	0.000403	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	6.75e-05	0.000399	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	6.7e-05	0.000396	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	6.64e-05	0.000393	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	6.62e-05	0.000392	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	6.62e-05	0.000391	CbGpPWpGaD
Ipratropium bromide—CYP2D6—brain—Parkinson's disease	6.6e-05	0.0092	CbGeAlD
Ipratropium bromide—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.59e-05	0.00039	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	6.59e-05	0.00039	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	6.57e-05	0.000389	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	6.55e-05	0.000388	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	6.54e-05	0.000387	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	6.51e-05	0.000385	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	6.51e-05	0.000385	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	6.45e-05	0.000382	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	6.42e-05	0.00038	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	6.41e-05	0.000379	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	6.39e-05	0.000378	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	6.38e-05	0.000378	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.38e-05	0.000378	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.36e-05	0.000376	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	6.33e-05	0.000374	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.3e-05	0.000373	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PENK—Parkinson's disease	6.25e-05	0.00037	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAG—Parkinson's disease	6.25e-05	0.00037	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PENK—Parkinson's disease	6.23e-05	0.000369	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAG—Parkinson's disease	6.23e-05	0.000369	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	6.21e-05	0.000367	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	6.19e-05	0.000366	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	6.18e-05	0.000366	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	6.18e-05	0.000366	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PENK—Parkinson's disease	6.17e-05	0.000365	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAG—Parkinson's disease	6.17e-05	0.000365	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	6.16e-05	0.000365	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	6.16e-05	0.000365	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	6.15e-05	0.000364	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PLA2G6—Parkinson's disease	6.13e-05	0.000363	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	6.13e-05	0.000363	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	6.1e-05	0.000361	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	6.1e-05	0.000361	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MAOB—Parkinson's disease	6.07e-05	0.000359	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	6.02e-05	0.000356	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—INSR—Parkinson's disease	5.92e-05	0.00035	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.88e-05	0.000348	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—DBH—Parkinson's disease	5.88e-05	0.000348	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GBA—Parkinson's disease	5.88e-05	0.000348	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.8e-05	0.000343	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	5.78e-05	0.000342	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.72e-05	0.000339	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	5.72e-05	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	5.7e-05	0.000337	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	5.64e-05	0.000334	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	5.61e-05	0.000332	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	5.61e-05	0.000332	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGB—Parkinson's disease	5.6e-05	0.000331	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	5.6e-05	0.000331	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	5.6e-05	0.000331	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	5.58e-05	0.00033	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	5.57e-05	0.000329	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	5.54e-05	0.000328	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	5.54e-05	0.000328	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	5.48e-05	0.000324	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	5.38e-05	0.000318	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	5.37e-05	0.000318	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	5.36e-05	0.000317	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	5.31e-05	0.000314	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	5.3e-05	0.000314	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	5.3e-05	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	5.25e-05	0.00031	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	5.21e-05	0.000308	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ND3—Parkinson's disease	5.07e-05	0.0003	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.07e-05	0.0003	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	4.98e-05	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	4.95e-05	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	4.93e-05	0.000292	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	4.89e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	4.86e-05	0.000288	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.77e-05	0.000282	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—OMD—Parkinson's disease	4.77e-05	0.000282	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.72e-05	0.000279	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	4.71e-05	0.000279	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	4.71e-05	0.000279	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.7e-05	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	4.66e-05	0.000276	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	4.64e-05	0.000275	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	4.6e-05	0.000272	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.52e-05	0.000267	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	4.52e-05	0.000267	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP2D6—Parkinson's disease	4.51e-05	0.000267	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	4.5e-05	0.000266	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	4.49e-05	0.000266	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	4.48e-05	0.000265	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	4.46e-05	0.000264	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	4.44e-05	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CTGF—Parkinson's disease	4.43e-05	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.33e-05	0.000256	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	4.32e-05	0.000255	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—DDC—Parkinson's disease	4.31e-05	0.000255	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.31e-05	0.000255	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	4.27e-05	0.000253	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—INSR—Parkinson's disease	4.17e-05	0.000247	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—INSR—Parkinson's disease	4.16e-05	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP2E1—Parkinson's disease	4.13e-05	0.000244	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—INSR—Parkinson's disease	4.12e-05	0.000244	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NQO1—Parkinson's disease	4.08e-05	0.000241	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.07e-05	0.000241	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—TH—Parkinson's disease	4.02e-05	0.000238	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	3.95e-05	0.000234	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGB—Parkinson's disease	3.94e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	3.93e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGB—Parkinson's disease	3.93e-05	0.000232	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	3.92e-05	0.000232	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	3.92e-05	0.000232	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	3.91e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGB—Parkinson's disease	3.89e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	3.88e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	3.87e-05	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYCS—Parkinson's disease	3.86e-05	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	3.86e-05	0.000228	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	3.85e-05	0.000228	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—DBH—Parkinson's disease	3.84e-05	0.000227	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GBA—Parkinson's disease	3.84e-05	0.000227	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.84e-05	0.000227	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	3.82e-05	0.000226	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	3.81e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	3.79e-05	0.000224	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	3.77e-05	0.000223	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	3.77e-05	0.000223	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	3.74e-05	0.000221	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.67e-05	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	3.67e-05	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	3.66e-05	0.000216	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.63e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	3.62e-05	0.000214	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NGF—Parkinson's disease	3.47e-05	0.000205	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	3.42e-05	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—COMT—Parkinson's disease	3.42e-05	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	3.41e-05	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTP1—Parkinson's disease	3.4e-05	0.000201	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MAOA—Parkinson's disease	3.4e-05	0.000201	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	3.38e-05	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—HMOX1—Parkinson's disease	3.36e-05	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	3.32e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	3.32e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	3.31e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	3.31e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	3.3e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	3.27e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	3.27e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ABCB1—Parkinson's disease	3.22e-05	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTM1—Parkinson's disease	3.13e-05	0.000185	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APOE—Parkinson's disease	3.07e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GPX1—Parkinson's disease	3e-05	0.000177	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—DDC—Parkinson's disease	2.82e-05	0.000167	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	2.78e-05	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	2.77e-05	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MTHFR—Parkinson's disease	2.76e-05	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	2.74e-05	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	2.69e-05	0.000159	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	2.68e-05	0.000158	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.66e-05	0.000158	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	2.66e-05	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	2.65e-05	0.000157	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.65e-05	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	2.65e-05	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	2.62e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—INS—Parkinson's disease	2.62e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOE—Parkinson's disease	2.57e-05	0.000152	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.47e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.44e-05	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NGF—Parkinson's disease	2.44e-05	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NGF—Parkinson's disease	2.43e-05	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.41e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TH—Parkinson's disease	2.41e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.4e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.37e-05	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	2.32e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	2.32e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.31e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.29e-05	0.000136	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—INS—Parkinson's disease	2.2e-05	0.00013	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOE—Parkinson's disease	2.16e-05	0.000128	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOE—Parkinson's disease	2.15e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.13e-05	0.000126	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—COMT—Parkinson's disease	2.05e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.04e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.03e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.01e-05	0.000119	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	1.95e-05	0.000115	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	1.94e-05	0.000115	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.93e-05	0.000114	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.87e-05	0.000111	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—INS—Parkinson's disease	1.84e-05	0.000109	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—INS—Parkinson's disease	1.84e-05	0.000109	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—INS—Parkinson's disease	1.82e-05	0.000108	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	1.79e-05	0.000106	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.79e-05	0.000106	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.76e-05	0.000104	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.73e-05	0.000102	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.65e-05	9.78e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.61e-05	9.55e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.6e-05	9.44e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TH—Parkinson's disease	1.57e-05	9.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOE—Parkinson's disease	1.54e-05	9.11e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.51e-05	8.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.37e-05	8.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.37e-05	8.1e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.36e-05	8.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.36e-05	8.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.36e-05	8.02e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.35e-05	7.97e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—COMT—Parkinson's disease	1.34e-05	7.91e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.33e-05	7.87e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.33e-05	7.86e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—INS—Parkinson's disease	1.31e-05	7.78e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.31e-05	7.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.26e-05	7.47e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.26e-05	7.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.26e-05	7.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.25e-05	7.37e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.22e-05	7.24e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.17e-05	6.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.14e-05	6.77e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.08e-05	6.39e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOE—Parkinson's disease	1.01e-05	5.95e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—INS—Parkinson's disease	8.6e-06	5.09e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—Parkinson's disease	8.06e-06	4.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—Parkinson's disease	8.03e-06	4.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—Parkinson's disease	7.96e-06	4.71e-05	CbGpPWpGaD
